Our Time Is Now

This is a moment of unprecedented promise in the race to end Alzheimer’s and all other dementia. Following years of sustained growth in philanthropic support and federal funding for dementia research driven by the Alzheimer’s Association, the national goal of preventing and effectively treating Alzheimer’s disease by 2025 is now within reach.

Modifiable risk factors are estimated to contribute to nearly four in 10 dementia cases globally, and the Association is leading and funding studies in multiple countries to evaluate lifestyle interventions designed to reduce risk of cognitive decline. At the same time, the U.S. Food and Drug Administration accelerated approval of the first treatments to address the underlying biology of Alzheimer’s disease begins a new era in Alzheimer’s treatment and research. History has shown us that approvals of the first drug in a new category can invigorate the field, increase investments in new treatments and generate greater innovation.

We have never been as optimistic as we are today that we are on the verge of something truly transformational. Our time is now, and together we will change the trajectory of this disease. We welcome your partnership!